- Home
- SER vs CCEL Comparison
SER vs CCEL Comparison
Compare SER & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- CCEL
- Stock Information
- Founded
- SER 2017
- CCEL 1989
- Country
- SER United States
- CCEL United States
- Employees
- SER N/A
- CCEL N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- CCEL Managed Health Care
- Sector
- SER Health Care
- CCEL Health Care
- Exchange
- SER Nasdaq
- CCEL Nasdaq
- Market Cap
- SER 46.7M
- CCEL 50.0M
- IPO Year
- SER 2018
- CCEL 1997
- Fundamental
- Price
- SER $6.13
- CCEL $7.81
- Analyst Decision
- SER
- CCEL
- Analyst Count
- SER 0
- CCEL 0
- Target Price
- SER N/A
- CCEL N/A
- AVG Volume (30 Days)
- SER 37.9K
- CCEL 12.9K
- Earning Date
- SER 11-12-2024
- CCEL 12-31-2024
- Dividend Yield
- SER N/A
- CCEL 3.13%
- EPS Growth
- SER N/A
- CCEL N/A
- EPS
- SER N/A
- CCEL N/A
- Revenue
- SER $3,157,500.00
- CCEL $31,838,476.00
- Revenue This Year
- SER N/A
- CCEL $3.97
- Revenue Next Year
- SER N/A
- CCEL $0.91
- P/E Ratio
- SER N/A
- CCEL N/A
- Revenue Growth
- SER 2454.55
- CCEL 1.95
- 52 Week Low
- SER $3.81
- CCEL $4.47
- 52 Week High
- SER $23.18
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- SER 58.82
- CCEL 42.90
- Support Level
- SER $4.15
- CCEL $7.60
- Resistance Level
- SER $6.24
- CCEL $9.10
- Average True Range (ATR)
- SER 0.73
- CCEL 0.28
- MACD
- SER 0.08
- CCEL -0.16
- Stochastic Oscillator
- SER 84.62
- CCEL 14.58
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.